Advisor Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $1.34M | Sell |
36,065
-4,677
| -11% | -$190K | 0.09% | 222 |
|
|
2022
Q1 | $1.8M | Buy |
40,742
+4,670
| +13% | +$202K | 0.11% | 180 |
|
|
2021
Q4 | $1.53M | Sell |
36,072
-740
| -2% | -$31.1K | 0.09% | 214 |
|
|
2021
Q3 | $1.6M | Sell |
36,812
-1,043
| -3% | -$46.1K | 0.11% | 181 |
|
|
2021
Q2 | $1.62M | Buy |
37,855
+439
| +1% | +$18.5K | 0.11% | 185 |
|
|
2021
Q1 | $1.45M | Buy |
37,416
+477
| +1% | +$18.1K | 0.1% | 193 |
|
|
2020
Q4 | $1.33M | Sell |
36,939
-5,644
| -13% | -$203K | 0.1% | 191 |
|
|
2020
Q3 | $1.63M | Buy |
42,583
+2,098
| +5% | +$80.8K | 0.14% | 144 |
|
|
2020
Q2 | $1.42M | Buy |
40,485
+5,179
| +15% | +$187K | 0.13% | 157 |
|
|
2020
Q1 | $1.15M | Sell |
35,306
-8,915
| -20% | -$348K | 0.14% | 149 |
|
|
2019
Q4 | $1.88M | Buy |
44,221
+270
| +0.6% | +$11.3K | 0.19% | 116 |
|
|
2019
Q3 | $1.79M | Buy |
43,951
+2,605
| +6% | +$110K | 0.22% | 102 |
|
|
2019
Q2 | $1.78M | Buy |
41,346
+426
| +1% | +$16.4K | 0.22% | 91 |
|
|
2019
Q1 | $1.57M | Sell |
40,920
-489
| -1% | -$18.7K | 0.2% | 95 |
|
|
2018
Q4 | $1.46M | Buy |
41,409
+6,343
| +18% | +$230K | 0.23% | 96 |
|
|
2018
Q3 | $1.35M | Sell |
35,066
-655
| -2% | -$22.9K | 0.18% | 102 |
|
|
2018
Q2 | $1.17M | Buy |
35,721
+4,118
| +13% | +$124K | 0.2% | 111 |
|
|
2018
Q1 | $863K | Sell |
31,603
-2,732
| -8% | -$74.3K | 0.16% | 140 |
|
|
2017
Q4 | $949K | Buy |
34,335
+7,398
| +27% | +$204K | 0.17% | 133 |
|
|
2017
Q3 | $786K | Sell |
26,937
-123
| -0.5% | -$3.4K | 0.15% | 140 |
|
|
2017
Q2 | $750K | Buy |
27,060
+5,396
| +25% | +$143K | 0.18% | 139 |
|
|
2017
Q1 | $539K | Buy |
21,664
+4,013
| +23% | +$97.6K | 0.14% | 176 |
|
|
2016
Q4 | $382K | Sell |
17,651
-270
| -2% | -$5.89K | 0.11% | 215 |
|
|
2016
Q3 | $427K | Sell |
17,921
-455
| -2% | -$10.9K | 0.14% | 175 |
|
|
2016
Q2 | $429K | Buy |
18,376
+935
| +5% | +$20.2K | 0.15% | 164 |
|
|
2016
Q1 | $328K | Buy |
17,441
+1,031
| +6% | +$18.1K | 0.12% | 203 |
|
|
2015
Q4 | $303K | Buy |
16,410
+1,037
| +7% | +$18.6K | 0.1% | 204 |
|
|
2015
Q3 | $252K | Sell |
15,373
-586
| -4% | -$10K | 0.11% | 228 |
|
|
2015
Q2 | $283K | Buy |
15,959
+593
| +4% | +$10.6K | 0.11% | 231 |
|
|
2015
Q1 | $273K | Buy |
15,366
+4,522
| +42% | +$71.5K | 0.12% | 232 |
|
|
2014
Q4 | $144K | Buy |
10,844
+197
| +2% | +$2.52K | 0.06% | 295 |
|
|
2014
Q3 | $126K | Buy |
+10,647
| New | +$134K | 0.07% | 229 |
|
Other funds holding BSX
BG
Advisor Partners's BSX Position: Q2 2022 in Review
Advisor Partners reduced its Boston Scientific (BSX) stake by 11% in Q2 2022, selling an estimated $190K and leaving 36,065 shares worth $1.34M. The position accounts for 0.09% of the portfolio, ranked #222.
Advisor Partners first reported a position in BSX in Q3 2014 and has held it in 32 quarters since. The position peaked at $1.88M in Q4 2019. 879 funds tracked by Wall St. Rank hold BSX as of Q2 2022.
- Advisor Partners held 36,065 shares of Boston Scientific worth $1.34M as of Q2 2022.
- Advisor Partners sold 4,677 Boston Scientific shares in Q2 2022, an estimated $190K.
- Boston Scientific made up 0.09% of Advisor Partners's portfolio in Q2 2022, its #222 holding.
- Advisor Partners first reported a position in Boston Scientific in Q3 2014 and has held it in 32 quarters since.
- Advisor Partners's Boston Scientific position peaked at $1.88M in Q4 2019.
- 879 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2022.
Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.